Clinical Study
Risk of Endophthalmitis in Boston Type 1 Keratoprosthesis Combined with Vitrectomy and Silicone Oil Insertion
Table 3
Characteristics of endophthalmitis cases.
| | | Underlying disease | BCVA before endophthalmitis (Snellen) | Time to endophthalmitis (postoperative month) | BCVA after endophthalmitis (Snellen) | End of follow-up (postoperative month) | Prophylactic topical antibiotic | Compliance at time of onset of endophthalmitis | Presence of BCL | Presence of GDI | Microbiology |
| | Case 1 | Multiple graft failures | 6/200 | 6 | HM | 24 | Polytrim + moxifloxacin 0.05% | Compliant | Yes | Yes | Negative | | Case 2 | Aniridia, limbal stem cell deficiency | 20/400 | 2 | 20/400 | 24 | Polytrim + ofloxacin 0.3% | Compliant | No | No | Staphylococcus aureus | | Case 3 | Herpetic keratitis, neurotrophic ulcer | 20/400 | 10 | 20/300 | 24 | Polytrim + moxifloxacin 0.05% | Compliant | No (lost in 6 months) | No | Coagulase-negative staphylococci | | Case 4 | Multiple graft failures | 1/200 | 3 | HM | 24 | Polytrim + ofloxacin 0.3% | Compliant | No (lost after 1 month) | Yes | Streptococcus pneumoniae | | Case 5 | Multiple graft failures | Counting fingers at 3 feet | 3 | Light perception | 12 | Polytrim + ofloxacin 0.3% | Compliant | Yes | No | Staphylococcus aureus |
|
|
BCVA: best-corrected visual acuity; BCL: bandage contact lens; GDI: glaucoma drainage implant; HM: hand movement.
|
